Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies
Clinical trial NCT06648785 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06648785
- Sponsor
- University of Vermont Medical Center
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2026-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.